BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23082798)

  • 1. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis.
    Kramer AH; Roberts DJ; Zygun DA
    Crit Care; 2012 Oct; 16(5):R203. PubMed ID: 23082798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Yamada T; Shojima N; Noma H; Yamauchi T; Kadowaki T
    Intensive Care Med; 2017 Jan; 43(1):1-15. PubMed ID: 27637719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive versus conventional insulin therapy in critically ill neurologic patients.
    Green DM; O'Phelan KH; Bassin SL; Chang CW; Stern TS; Asai SM
    Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of hyperglycemic control in pediatric intensive care.
    Macrae D; Grieve R; Allen E; Sadique Z; Morris K; Pappachan J; Parslow R; Tasker RC; Elbourne D;
    N Engl J Med; 2014 Jan; 370(2):107-18. PubMed ID: 24401049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal glycemic control in neurocritical care patients.
    Bilotta F; Rosa G
    Crit Care; 2012 Oct; 16(5):163. PubMed ID: 23106972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control targets after traumatic brain injury: a systematic review and meta-analysis.
    Hermanides J; Plummer MP; Finnis M; Deane AM; Coles JP; Menon DK
    Crit Care; 2018 Jan; 22(1):11. PubMed ID: 29351760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.
    Graffagnino C; Gurram AR; Kolls B; Olson DM
    Neurocrit Care; 2010 Dec; 13(3):307-12. PubMed ID: 21086066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.
    Wiener RS; Wiener DC; Larson RJ
    JAMA; 2008 Aug; 300(8):933-44. PubMed ID: 18728267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
    Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
    Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials.
    Zhao Y; Wu Y; Xiang B
    Pediatr Res; 2018 Jul; 84(1):22-27. PubMed ID: 29795449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight Glycemic Control in Critically Ill Children.
    Agus MS; Wypij D; Hirshberg EL; Srinivasan V; Faustino EV; Luckett PM; Alexander JL; Asaro LA; Curley MA; Steil GM; Nadkarni VM;
    N Engl J Med; 2017 Feb; 376(8):729-741. PubMed ID: 28118549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in the medical intensive care unit.
    Kovalaske MA; Gandhi GY
    J Diabetes Sci Technol; 2009 Nov; 3(6):1330-41. PubMed ID: 20144387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.
    Griesdale DE; de Souza RJ; van Dam RM; Heyland DK; Cook DJ; Malhotra A; Dhaliwal R; Henderson WR; Chittock DR; Finfer S; Talmor D
    CMAJ; 2009 Apr; 180(8):821-7. PubMed ID: 19318387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective operationalization and feasibility of a glycemic control protocol in critically ill children.
    Branco RG; Xavier L; Garcia PC; Piva JP; Fiori HH; Baldisserotto M; Fiori RM; Tasker RC
    Pediatr Crit Care Med; 2011 May; 12(3):265-70. PubMed ID: 20935589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials.
    Ling Y; Li X; Gao X
    Eur J Intern Med; 2012 Sep; 23(6):564-74. PubMed ID: 22863436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials.
    Zhao Y; Wu Y; Xiang B
    Pediatr Res; 2018 May; 83(5):930-935. PubMed ID: 29244792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of intensive glycemic control therapy in patients with traumatic brain injury: A systematic review and meta-analysis of randomized controlled trials.
    Zhu C; Chen J; Pan J; Qiu Z; Xu T
    Medicine (Baltimore); 2018 Jul; 97(30):e11671. PubMed ID: 30045323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
    Klonoff DC
    J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.